ENDRA Life Sciences  logo
ENDRA Life Sciences NDRA
$ 5.27 3.85%

Quarterly report 2024-Q2
added 08-14-2024

report update icon

ENDRA Life Sciences Income Statement 2011-2024 | NDRA

Annual Income Statement ENDRA Life Sciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

6.03 M 11.6 M 911 K 36.5 M 11.2 M 9.82 M 9.37 M - - - - - -

Shares

10.4 M 3.17 M 2.13 M 19.2 M 7.5 M 4.5 M 2.76 M - - - - - -

Historical Prices

0.58 3.67 0.428 2.5 1.1 1.65 3.04 - - - - - -

Net Income

-10.1 M -13.2 M -11.2 M -11.7 M -13.3 M -9.8 M -5.38 M -2.78 M -2.28 M -2.18 M - - -

Revenue

- - - - - 6.17 K 352 K 516 K 1.41 M 559 K - - -

Cost of Revenue

- - - - - - 173 K - - - - - -

Gross Profit

- - - - - 6.17 K 179 K 280 K 744 K 300 K - - -

Operating Income

-10.5 M -13.2 M -11.5 M -11.5 M -10.8 M -9.02 M -4.63 M -1.79 M - - - - -

Interest Expense

460 K -21.5 K -41.5 K 8.84 K -107 K -48 K 42.6 K 72 K - - - - -

EBITDA

-10.4 M -13.1 M -11.4 M -11.3 M -10.7 M -8.66 M -4.56 M -1.73 M -1.5 M -1.49 M - - -

Operating Expenses

10.5 M 13.2 M 11.5 M - 10.8 M 8.74 M 4.8 M 2.07 M 2.31 M 1.83 M - - -

General and Administrative Expenses

4.7 M 5.17 M 4.94 M 5 M 3.86 M 3.75 M 2.75 M 1.54 M 1.22 M 897 K - - -

All numbers in USD currency

Quarterly Income Statement ENDRA Life Sciences

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

72.4 M 10.9 M 10.4 M 8.41 M 7.48 M 3.17 M 3.17 M 63.2 M 63.2 M 43.1 M 42.6 M 41.9 M 41.7 M 37.8 M 34 M 23.9 M 14.7 M 11.5 M 8.42 M 7.43 M 7.42 M 7.42 M 7.42 M 3.93 M 3.92 M 3.92 M 3.92 M 3.91 M 2.44 M 723 K 723 K 723 K 723 K 723 K - - - - - - - - - - - - - - - - - - - -

Net Income

-2.23 M -2.78 M - -3.1 M -2.56 M -2.94 M - -3.44 M -3.59 M -2.86 M - -2.66 M -3.2 M -2.27 M - -3.26 M -2.89 M -3.32 M - -3.41 M -2.33 M -2.75 M - -2.76 M -1.85 M -2.83 M - -909 K -1.43 M -742 K - -978 K -729 K -379 K - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - 6.17 K - 287 K 57.8 K - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - 118 K 51.4 K - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - 6.17 K - 169 K 6.34 K - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-2.23 M -2.78 M - -3.13 M -2.99 M -2.94 M - -3.42 M -3.57 M -2.86 M - -2.65 M -3.2 M -2.58 M - -3.26 M -2.89 M -3.1 M - -2.64 M -2.33 M -2.75 M - -2.36 M -1.82 M -2.84 M - -911 K -1.06 M -361 K - -605 K -494 K -373 K - - - - - - - - - - - - - - - - - - - -

Interest Expense

1.7 K -4.84 K - 28.2 K - - - - - - - -7.51 K 1.09 K -2.04 K - -2.62 K 1.26 K 6.62 K - -44.6 K -9.2 K -1.52 K - -25.5 K -23.7 K 12.3 K - 2.03 K 374 K 28.1 K - 373 K 235 K -6.02 K - - - - - - - - - - - - - - - - - - - -

EBITDA

- -2.77 M - -3.1 M -2.96 M -2.9 M - -3.35 M -3.55 M -2.84 M - -2.56 M -3.14 M -2.54 M - -3.21 M -2.85 M -3.08 M - -2.58 M -2.29 M -2.73 M - -2.31 M -1.79 M -2.82 M - -865 K -1.03 M -345 K - -556 K -462 K -357 K - - - - - - - - - - - - - - - - - - - -

Operating Expenses

2.23 M 2.78 M - 3.13 M 2.99 M 2.94 M - 3.42 M 3.57 M 2.86 M - 2.65 M 3.2 M 2.58 M - 3.26 M 2.89 M 3.1 M - 2.64 M 2.33 M 2.75 M - 2.36 M 1.82 M 2.84 M - 1.08 M 1.06 M 361 K - 605 K 494 K 373 K - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

1.35 M 1.5 M - 1.25 M 1.35 M 1.37 M - 1.17 M 1.38 M 1.3 M - 1.2 M 1.2 M 1.27 M - 1.35 M 1.27 M 1.47 M - 1.07 M 932 K 917 K - 833 K 942 K 1.07 M - 732 K 882 K 264 K - 452 K 385 K 274 K - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency